Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Orphi Therapeutics

Orphi Therapeutics
Accelerator/Inc LATEST DEAL TYPE

Operator of a biotechnology company intended to develop pharmacological chaperones (PCs) for the treatment of monogenic diseases. The company is developing novel therapies for MC4R-linked monogenic obesity and Sandhoff/Tay Sachs disease, providing patients with medical therapy that can treat blood disorders, cerebral amyloid angiopathy or "CAA," which can cause strokes.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 2351 Faraday Avenue
  • Carlsbad, CA 92008
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Orphi Therapeutics’s full profile, request a free trial.

Orphi Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 21-Jan-2019 00000 Completed Product Development
4. Grant 01-Jan-2017 00.000 00000 Completed Product Development
3. Grant 17-Sep-2015 0000 00000 Completed Product Development
2. Early Stage VC 18-May-2015 $650K $650K Completed Product Development
1. Grant 01-Jan-2015 $375K Completed Product Development
To view this company’s complete deal history including valuation and funding, request access »

Orphi Therapeutics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
JLABS Accelerator/Incubator Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Canavan Foundation Corporation 000 0000 000000 0
National Tay-Sachs & Allied Diseases Association Corporation 000 0000 000000 0
Mercury Fund Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Orphi Therapeutics Executive Team (3)

Name Title Board
Brandon Wustman Ph.D Chief Executive Officer & Co-Founder
Eric Sjoberg Co-Founder, Chief Financial Officer & Vice President of Preclinical Development
John Steele IV Co-Founder & Board Member

Orphi Therapeutics Board Members (1)

Name Representing Role Since Contact
John Steele IV Orphi Therapeutics Co-Founder & Board Member 000 0000